LEXEO THERAPEUTICS INC (LXEO) Stock Income Statement
NASDAQ:LXEO - Nasdaq - US52886X1072 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 650.00K | 1.66M | 520.00K | |||
| Operating Expenses | 116.28M | 68.51M | 61.16M | 52.29M | 5.11M | |||
| Research and Development | 75.52M | 53.13M | 49.16M | 45.12M | 4.32M | |||
| Selling, General, and Administrative Expenses | 40.76M | 15.38M | 12.00M | 7.17M | 790.00K | |||
| Operating Income | -116.28M | -68.51M | -60.51M | -50.64M | -4.59M | |||
| Interest Income/Expense | 6.97M | 2.65M | 1.23M | 20.00K | -150.00K | |||
| Other Income/Expense | 15.00K | -530.00K | 0.00 | 0.00 | 0.00 | |||
| Non Recurring Items | N/A | N/A | N/A | 0.00 | -420.00K | |||
| Income Before Taxes | -109.31M | -66.39M | -59.28M | -50.62M | -5.15M | |||
| Income Tax | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Net Income | -109.31M | -66.39M | -59.28M | -50.62M | -5.15M | |||
| EBITDA | -113.93M | -66.67M | -60.24M | -50.63M | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.31 | -2.69 | -2.40 | -2.05 | -0.21 | |||
| Non GAAP EPS | -3.30 | N/A | N/A | N/A | N/A | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | -9120.00% | -3049.40% | -990.38% | |||
| Operating Profit Margin | N/A | N/A | -9309.23% | -3050.60% | -882.69% | |||
All data in USD